Rezolute, Inc.
Nasdaq: RZLTPharmaceutical Preparations · Entity-resolved by Clous
CIK0001509261
TickerRZLT
ExchangeNasdaq
SIC2834
StateNV
FY end06-30
Illustrative profile — live data lights up when a server API key is configured.
Key financials
Revenue
—
—
Net IncomeFY2025-06-30
-$74.41M
-8.7% YoY
Total AssetsFY2025-06-30
$175.49M
+32.2% YoY
EquityFY2025-06-30
$162.13M
+34.0% YoY
Shares OutstandingFY2025-06-30
90.81M
—
Operating Cash FlowFY2025-06-30
-$69.08M
-20.4% YoY
Market
Market
RZLTClose price
$5.04
Market cap
$485.31M
delayed EOD · as of 2026-06-18
Short interest & fails
Short-sale volume
FINRA Reg SHO · daily71.8%
short of total volume · 2026-06-18
2026-06-1871.8%
2026-06-1759.3%
2026-06-1660.0%
2026-06-1552.5%
2026-06-1256.9%
Fails-to-deliver
SEC CNS fails · semi-monthly389
shares failed · 2026-05-13
2026-05-13389 sh$3.30
2026-04-207.9K sh$3.46
2026-04-13149 sh$3.64
2026-04-06327 sh$3.12
2026-03-31245.05K sh$2.85
Short volume (FINRA Reg SHO) · fails-to-deliver (SEC) · borrow fee (broker securities-lending feed) — via the Clous API.
| Concept | FY2022-06-30 | FY2023-06-30 | FY2024-06-30 | FY2025-06-30 | YoY | % rev |
|---|---|---|---|---|---|---|
| Net Income | -$41.06M | -$51.79M | -$68.46M | -$74.41M | -8.7% | — |
| Total Assets | $152.42M | $123.72M | $132.74M | $175.49M | +32.2% | — |
| Equity | $149.47M | $116.17M | $121M | $162.13M | +34.0% | — |
| Operating Cash Flow | -$39.62M | -$44.48M | -$57.37M | -$69.08M | -20.4% | — |
| Shares Outstanding | — | — | — | 90.81M | — | — |
Get this entity — and 970.89K+ others — programmatically.
One clean JSON shape, resolved IDs, MCP-native. Query the same data behind this page.
GET /v1/entities?cik=0001509261